Sirona Biochem Corp V.SBM

Told you so

[Crazydan]

They have nothing going on!!!! Plain and simple!!! Got out at .25 best move I made in 3 years.

[skiboard09]

Yup wish I had sold more. Now bag holding a big chunk. Thought we would finally see something.   

[skiboard09]

We need some Biorun info 

[PeterG]

Guys, I got some very confidential information about the next quarterly update: Tfc-039 we are now in discussion with 6!!! Global companies, but as we have lost the overview about all these great companies, we are happy to announce, that we have nothing more to announce. Due to confidentiality, we can't provide more information. But we can trust you to make decisions in line with shareholders

[sakinny3]

It must be very frustrating for Howard and team to be sitting there watching shareholders lose money when they know all that fantastic news but just can't tell us. I'm sure those that sold at a loss will understand, must be quite a few given how high the price was earlier in the year

[forhandlaren]

Well, they put themselves in a bad situation.  It was a lousy decision to let a possible customer to finance the 0.4 percent concentration clinical trial with TFC-1067. They should have financed it internally. Downsides: - while we wait the 0.2 concentration cannot be licensed to anyone else! - since 0.2 cannot be licensed, the share price is not supported in any way - seem like they

[bazooka73]

In my opinion, it's now not about the concentratio  of 1067, it's about 1067 all in all. If the so called top10 pharma company decides take over the molecule, they of course don't want to share it with others but keep it as exclusivly as possible. That's why - imho- Sirona just did one non-exclusive deal with R&F. And furthermore - again imho - the so called deal with R

[forhandlaren]

I'm fully aware of the rationale to gain street cred with R+F and sell the moleculy in a global license regardless of competition.  The main concern is that fair competition between potential buyers were killed by the bad setup and therefore revenue is far from maximed because of a sole bidder. They should have kept the 0.2 to be licensed by anyone. We should then have seen a share

[Transperance]

Forhandlaren, I can only agree with you. If Sirona financed the clinical study themselves, they could indeed have invited all interested third parties and not only one. The gain by having the study financed by a third party is negligible compared to a situation of competition among the third parties. Now, the question is whether terms were negotiated and agreed with the third party ex ante or ex

[skiboard09]

The higher concentration 1067 is just ONE thing we should be hearing about. don't forget the list of other milestones we are still way past overdue on. Why can't they keep to a timeline they published.. what is Howard doing?  I feel like a new CEO announcement and we would double in value. People are tired of not hitting the timelines they give to shareholders. It's the same old

[Ticklel1st]

I'm sure that If I had as many failures in my real job as we are seeing here,  I would have been fired by now. I don't think this is all mnagements fault...well maybe I do.

[skiboard09]

We will be middle of September this week and have gotten nothing. Wasn't entire milestone list suppose to be complete by end of June? 2.5 months past that and that timeline was already extended and delayed. How can they literally put out something that was so far off. Anyone ?  Management ? 

[Ticklel1st]

Skid. But everything is on track that was started 5 years ago except there has been some delays. Don't worry, be happy management is still on the bottom of things and our expesive part time managemnet team are doing  possible to create shareholder value for the couple of hours they spend on behalf of shareholders between their  real jobs. I appreaciate their valuable time working on